Phagosomal removal of fungal melanin reprograms macrophage metabolism to promote antifungal immunity.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
08 05 2020
Historique:
received: 19 07 2019
accepted: 14 04 2020
entrez: 10 5 2020
pubmed: 10 5 2020
medline: 6 8 2020
Statut: epublish

Résumé

In response to infection, macrophages adapt their metabolism rapidly to enhance glycolysis and fuel specialized antimicrobial effector functions. Here we show that fungal melanin is an essential molecule required for the metabolic rewiring of macrophages during infection with the fungal pathogen Aspergillus fumigatus. Using pharmacological and genetic tools, we reveal a molecular link between calcium sequestration by melanin inside the phagosome and induction of glycolysis required for efficient innate immune responses. By remodeling the intracellular calcium machinery and impairing signaling via calmodulin, melanin drives an immunometabolic signaling axis towards glycolysis with activation of hypoxia-inducible factor 1 subunit alpha (HIF-1α) and phagosomal recruitment of mammalian target of rapamycin (mTOR). These data demonstrate a pivotal mechanism in the immunometabolic regulation of macrophages during fungal infection and highlight the metabolic repurposing of immune cells as a potential therapeutic strategy.

Identifiants

pubmed: 32385235
doi: 10.1038/s41467-020-16120-z
pii: 10.1038/s41467-020-16120-z
pmc: PMC7210971
doi:

Substances chimiques

Hypoxia-Inducible Factor 1, alpha Subunit 0
Lactates 0
Melanins 0
TOR Serine-Threonine Kinases EC 2.7.11.1
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2282

Subventions

Organisme : Medical Research Council
ID : MR/N006364/2
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 102705
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N006364/1
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Références

O’Neill, L. A. & Pearce, E. J. Immunometabolism governs dendritic cell and macrophage function. J. Exp. Med. 213, 15–23 (2016).
pubmed: 26694970 pmcid: 4710204 doi: 10.1084/jem.20151570
Van den Bossche, J., O’Neill, L. A. & Menon, D. Macrophage immunometabolism: where are we (going)? Trends Immunol. 38, 395–406 (2017).
pubmed: 28396078 doi: 10.1016/j.it.2017.03.001
Millet, P., Vachharajani, V., McPhail, L., Yoza, B. & McCall, C. E. GAPDH binding to TNF-alpha mRNA contributes to posttranscriptional repression in monocytes: a novel mechanism of communication between inflammation and metabolism. J. Immunol. 196, 2541–2551 (2016).
pubmed: 4779706 pmcid: 4779706 doi: 10.4049/jimmunol.1501345
Palsson-McDermott, E. M. et al. Pyruvate kinase M2 regulates Hif-1alpha activity and IL-1beta induction and is a critical determinant of the warburg effect in LPS-activated macrophages. Cell Metab. 21, 65–80 (2015).
pubmed: 25565206 pmcid: 5198835 doi: 10.1016/j.cmet.2014.12.005
Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419–430 (2015).
pubmed: 25786174 doi: 10.1016/j.immuni.2015.02.005
Lampropoulou, V. et al. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab. 24, 158–166 (2016).
pubmed: 27374498 pmcid: 5108454 doi: 10.1016/j.cmet.2016.06.004
Mills, E. L. et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell 167, 457–470 e413 (2016).
pubmed: 27667687 pmcid: 5863951 doi: 10.1016/j.cell.2016.08.064
Van den Bossche, J. et al. Mitochondrial dysfunction prevents repolarization of inflammatory macrophages. Cell Rep. 17, 684–696 (2016).
pubmed: 27732846 doi: 10.1016/j.celrep.2016.09.008
Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature 496, 238–242 (2013).
pubmed: 23535595 pmcid: 4031686 doi: 10.1038/nature11986
Stienstra, R., Netea-Maier, R. T., Riksen, N. P., Joosten, L. A. B. & Netea, M. G. Specific and complex reprogramming of cellular metabolism in myeloid cells during innate immune responses. Cell Metab. 26, 142–156 (2017).
pubmed: 28683282 doi: 10.1016/j.cmet.2017.06.001
Cheng, S. C. et al. mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345, 1250684 (2014).
pubmed: 25258083 pmcid: 4226238 doi: 10.1126/science.1250684
Lachmandas, E. et al. Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells. Eur. J. Immunol. 46, 2574–2586 (2016).
pubmed: 27624090 pmcid: 5129526 doi: 10.1002/eji.201546259
Wickersham, M. et al. Metabolic stress drives keratinocyte defenses against Staphylococcus aureus infection. Cell Rep. 18, 2742–2751 (2017).
pubmed: 28297676 pmcid: 6799992 doi: 10.1016/j.celrep.2017.02.055
Lachmandas, E. et al. Microbial stimulation of different Toll-like receptor signalling pathways induces diverse metabolic programmes in human monocytes. Nat. Microbiol. 2, 16246 (2016).
pubmed: 27991883 doi: 10.1038/nmicrobiol.2016.246
Netea, M. G., Joosten, L. A., van der Meer, J. W., Kullberg, B. J. & van de Veerdonk, F. L. Immune defence against Candida fungal infections. Nat. Rev. Immunol. 15, 630–642 (2015).
pubmed: 26388329 doi: 10.1038/nri3897
van de Veerdonk, F. L., Gresnigt, M. S., Romani, L., Netea, M. G. & Latge, J. P. Aspergillus fumigatus morphology and dynamic host interactions. Nat. Rev. Microbiol. 15, 661–674 (2017).
pubmed: 28919635 doi: 10.1038/nrmicro.2017.90
Arts, R. J. et al. Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity. Cell Metab. 24, 807–819 (2016).
pubmed: 27866838 pmcid: 5742541 doi: 10.1016/j.cmet.2016.10.008
Bekkering, S. et al. Metabolic induction of trained immunity through the mevalonate pathway. Cell 172, 135–146 e139 (2018).
pubmed: 29328908 doi: 10.1016/j.cell.2017.11.025
Dominguez-Andres, J. et al. The itaconate pathway is a central regulatory node linking innate immune tolerance and trained immunity. Cell Metab. 29, 211–22 (2018).
Dominguez-Andres, J. et al. Rewiring monocyte glucose metabolism via C-type lectin signaling protects against disseminated candidiasis. PLoS Pathog. 13, e1006632 (2017).
pubmed: 28922415 pmcid: 5619837 doi: 10.1371/journal.ppat.1006632
Cheng, S. C. et al. Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat. Immunol. 17, 406–413 (2016).
pubmed: 26950237 doi: 10.1038/ni.3398
Tucey, T. M. et al. Glucose homeostasis is important for immune cell viability during candida challenge and host survival of systemic fungal infection. Cell Metab. 27, 988–1006 e1007 (2018).
pubmed: 29719235 pmcid: 6709535 doi: 10.1016/j.cmet.2018.03.019
Segal, B. H. Aspergillosis. N. Engl. J. Med. 360, 1870–1884 (2009).
pubmed: 19403905 doi: 10.1056/NEJMra0808853
Brown, G. D. et al. Hidden killers: human fungal infections. Sci. Transl. Med. 4, 165rv113 (2012).
doi: 10.1126/scitranslmed.3004404
Maertens, J. A. et al. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. Lancet 387, 760–769 (2016).
pubmed: 26684607 doi: 10.1016/S0140-6736(15)01159-9
Herbst, S. et al. Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus. EMBO Mol. Med. 7, 240–258 (2015).
pubmed: 25637383 pmcid: 4364943 doi: 10.15252/emmm.201404556
Shah, A. et al. Calcineurin orchestrates lateral transfer of Aspergillus fumigatus during macrophage cell death. Am. J. Respir. Crit. Care Med. 194, 1127–1139 (2016).
pubmed: 27163634 pmcid: 5114448 doi: 10.1164/rccm.201601-0070OC
Espinosa, V. et al. Inflammatory monocytes orchestrate innate antifungal immunity in the lung. PLoS Pathog. 10, e1003940 (2014).
pubmed: 24586155 pmcid: 3930594 doi: 10.1371/journal.ppat.1003940
Cunha, C. et al. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. Blood 116, 5394–5402 (2010).
pubmed: 20807886 doi: 10.1182/blood-2010-04-279307
Cunha, C. et al. IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity. J. Allergy Clin. Immunol. 140, 867–870 e869 (2017).
pubmed: 28389392 doi: 10.1016/j.jaci.2017.02.034
Gresnigt, M. S. et al. Genetic deficiency of NOD2 confers resistance to invasive aspergillosis. Nat. Commun. 9, 2636 (2018).
pubmed: 29980664 pmcid: 6035256 doi: 10.1038/s41467-018-04912-3
Stappers, M. H. T. et al. Recognition of DHN-melanin by a C-type lectin receptor is required for immunity to Aspergillus. Nature 555, 382–386 (2018).
pubmed: 29489751 pmcid: 5857201 doi: 10.1038/nature25974
Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417–425 (2015).
pubmed: 26771021 pmcid: 4707969 doi: 10.1016/j.cels.2015.12.004
Parikh, H. et al. TXNIP regulates peripheral glucose metabolism in humans. PLoS Med. 4, e158 (2007).
pubmed: 17472435 pmcid: 1858708 doi: 10.1371/journal.pmed.0040158
Latge, J. P., Beauvais, A. & Chamilos, G. The cell wall of the human fungal pathogen aspergillus fumigatus: biosynthesis, organization, immune response, and virulence. Annu. Rev. Microbiol. 71, 99–116 (2017).
pubmed: 28701066 doi: 10.1146/annurev-micro-030117-020406
Aimanianda, V. et al. Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature 460, 1117–1121 (2009).
pubmed: 19713928 doi: 10.1038/nature08264
Jahn, B. et al. Isolation and characterization of a pigmentless-conidium mutant of Aspergillus fumigatus with altered conidial surface and reduced virulence. Infect. Immun. 65, 5110–5117 (1997).
pubmed: 9393803 pmcid: 175736 doi: 10.1128/IAI.65.12.5110-5117.1997
Sarfati, J. et al. A new experimental murine aspergillosis model to identify strains of Aspergillus fumigatus with reduced virulence. Nihon Ishinkin Gakkai Zasshi 43, 203–213 (2002).
pubmed: 12402022 doi: 10.3314/jjmm.43.203
Langfelder, K., Streibel, M., Jahn, B., Haase, G. & Brakhage, A. A. Biosynthesis of fungal melanins and their importance for human pathogenic fungi. Fungal Genet. Biol. 38, 143–158 (2003).
pubmed: 12620252 doi: 10.1016/S1087-1845(02)00526-1
Duvel, K. et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 39, 171–183 (2010).
pubmed: 20670887 pmcid: 2946786 doi: 10.1016/j.molcel.2010.06.022
Dibble, C. C. & Cantley, L. C. Regulation of mTORC1 by PI3K signaling. Trends Cell Biol. 25, 545–555 (2015).
pubmed: 26159692 pmcid: 4734635 doi: 10.1016/j.tcb.2015.06.002
Majumder, P. K. et al. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat. Med. 10, 594–601 (2004).
pubmed: 15156201 doi: 10.1038/nm1052
Kyrmizi, I. et al. Calcium sequestration by fungal melanin inhibits calcium-calmodulin signalling to prevent LC3-associated phagocytosis. Nat. Microbiol. 3, 791–803 (2018).
pubmed: 29849062 doi: 10.1038/s41564-018-0167-x
Raffaello, A., Mammucari, C., Gherardi, G. & Rizzuto, R. Calcium at the center of cell signaling: interplay between endoplasmic reticulum, mitochondria, and lysosomes. Trends Biochem. Sci. 41, 1035–1049 (2016).
pubmed: 27692849 pmcid: 5123979 doi: 10.1016/j.tibs.2016.09.001
Liou, J. et al. STIM is a Ca
pubmed: 16005298 pmcid: 3186072 doi: 10.1016/j.cub.2005.05.055
Howard, N. C. et al. Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes. Nat. Microbiol. 3, 1099–1108 (2018).
pubmed: 30224802 pmcid: 6158078 doi: 10.1038/s41564-018-0245-0
Akoumianaki, T. et al. Aspergillus cell wall melanin blocks LC3-associated phagocytosis to promote pathogenicity. Cell Host Microbe. 19, 79–90 (2016).
pubmed: 26749442 doi: 10.1016/j.chom.2015.12.002
Thywissen, A. et al. Conidial dihydroxynaphthalene melanin of the human pathogenic fungus Aspergillus fumigatus interferes with the host endocytosis pathway. Front. Microbiol. 2, 96 (2011)
pubmed: 21747802 pmcid: 3128974 doi: 10.3389/fmicb.2011.00096
Volling, K., Thywissen, A., Brakhage, A. A. & Saluz, H. P. Phagocytosis of melanized Aspergillus conidia by macrophages exerts cytoprotective effects by sustained PI3K/Akt signalling. Cell. Microbiol. 13, 1130–1148 (2011).
pubmed: 21501368 doi: 10.1111/j.1462-5822.2011.01605.x
Ugolini, M. & Sander, L. E. Dead or alive: how the immune system detects microbial viability. Curr. Opin. Immunol. 56, 60–66 (2018).
pubmed: 30366275 doi: 10.1016/j.coi.2018.09.018
Moretti, J. et al. STING senses microbial viability to orchestrate stress-mediated autophagy of the endoplasmic reticulum. Cell 171, 809–823 e813 (2017).
pubmed: 29056340 pmcid: 5811766 doi: 10.1016/j.cell.2017.09.034
Briard, B. et al. Fungal ligands released by innate immune effectors promote inflammasome activation during Aspergillus fumigatus infection. Nat. Microbiol. 4, 316–327 (2019).
pubmed: 30510167 doi: 10.1038/s41564-018-0298-0
Karki, R. et al. Concerted activation of the AIM2 and NLRP3 inflammasomes orchestrates host protection against Aspergillus infection. Cell Host Microbe. 17, 357–368 (2015).
pubmed: 25704009 pmcid: 4359672 doi: 10.1016/j.chom.2015.01.006
Willger, S. D., Grahl, N. & Cramer, R. A. Jr. Aspergillus fumigatus metabolism: clues to mechanisms of in vivo fungal growth and virulence. Med. Mycol. 47(Suppl 1), S72–S79 (2009).
pubmed: 19253141 pmcid: 2905159 doi: 10.1080/13693780802455313
Schmidt, H. et al. Proteomics of Aspergillus fumigatus conidia-containing phagolysosomes identifies processes governing immune evasion. Mol. Cell. Proteom. 17, 1084–1096 (2018).
doi: 10.1074/mcp.RA117.000069
Scheffler, J. M. et al. LAMTOR2 regulates dendritic cell homeostasis through FLT3-dependent mTOR signalling. Nat. Commun. 5, 5138 (2014).
pubmed: 25336251 pmcid: 4220488 doi: 10.1038/ncomms6138
Sakamoto, T. et al. Hypoxia-inducible factor 1 regulation through cross talk between mTOR and MT1-MMP. Mol. Cell. Biol. 34, 30–42 (2014).
pubmed: 24164895 pmcid: 3911284 doi: 10.1128/MCB.01169-13
Shepardson, K. M. et al. Myeloid derived hypoxia inducible factor 1-alpha is required for protection against pulmonary Aspergillus fumigatus infection. PLoS Pathog. 10, e1004378 (2014).
pubmed: 25255025 pmcid: 4177996 doi: 10.1371/journal.ppat.1004378
Fliesser, M. et al. Hypoxia-inducible factor 1alpha modulates metabolic activity and cytokine release in anti-Aspergillus fumigatus immune responses initiated by human dendritic cells. Int J. Med. Mycol. 305, 865–873 (2015).
Corretti, M. C. et al. Glycolytic inhibition and calcium overload as consequences of exogenously generated free radicals in rabbit hearts. J. Clin. Invest. 88, 1014–1025 (1991).
pubmed: 1653271 pmcid: 295509 doi: 10.1172/JCI115361
Takagaki, G. Control of aerobic glycolysis and pyruvate kinase activity in cerebral cortex slices. J. Neurochem. 15, 903–916 (1968).
pubmed: 4234623 doi: 10.1111/j.1471-4159.1968.tb11632.x
Krajcovic, M., Krishna, S., Akkari, L., Joyce, J. A. & Overholtzer, M. mTOR regulates phagosome and entotic vacuole fission. Mol. Biol. Cell 24, 3736–3745 (2013).
pubmed: 24088573 pmcid: 3842999 doi: 10.1091/mbc.e13-07-0408
Shen, K. & Sabatini, D. M. Ragulator and SLC38A9 activate the Rag GTPases through noncanonical GEF mechanisms. Proc. Natl. Acad. Sci. USA 115, 9545–9550 (2018).
pubmed: 30181260 doi: 10.1073/pnas.1811727115
da Silva Ferreira, M. E. et al. The akuB(KU80) mutant deficient for nonhomologous end joining is a powerful tool for analyzing pathogenicity in Aspergillus fumigatus. Eukaryot. Cell 5, 207–211 (2006).
pubmed: 16400184 pmcid: 1360264 doi: 10.1128/EC.5.1.207-211.2006
Tsai, H. F., Washburn, R. G., Chang, Y. C. & Kwon-Chung, K. J. Aspergillus fumigatus arp1 modulates conidial pigmentation and complement deposition. Mol. Microbiol. 26, 175–183 (1997).
pubmed: 9383199 doi: 10.1046/j.1365-2958.1997.5681921.x
Tsai, H. F., Wheeler, M. H., Chang, Y. C. & Kwon-Chung, K. J. A developmentally regulated gene cluster involved in conidial pigment biosynthesis in Aspergillus fumigatus. J. Bacteriol. 181, 6469–6477 (1999).
pubmed: 10515939 pmcid: 103784 doi: 10.1128/JB.181.20.6469-6477.1999
Bayry, J. et al. Surface structure characterization of Aspergillus fumigatus conidia mutated in the melanin synthesis pathway and their human cellular immune response. Infect. Immun. 82, 3141–3153 (2014).
pubmed: 24818666 pmcid: 4136205 doi: 10.1128/IAI.01726-14
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5, 621–628 (2008).
pubmed: 18516045 doi: 10.1038/nmeth.1226
Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).
pubmed: 19910308 pmcid: 19910308 doi: 10.1093/bioinformatics/btp616
Misharin, A. V., Morales-Nebreda, L., Mutlu, G. M., Budinger, G. R. & Perlman, H. Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung. Am. J. Respir. Cell Mol. Biol. 49, 503–510 (2013).
pubmed: 23672262 pmcid: 3824047 doi: 10.1165/rcmb.2013-0086MA

Auteurs

Samuel M Gonçalves (SM)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal.
ICVS/3B's - PT Government Associate Laboratory, Guimarães/Braga, Portugal.

Cláudio Duarte-Oliveira (C)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal.
ICVS/3B's - PT Government Associate Laboratory, Guimarães/Braga, Portugal.

Cláudia F Campos (CF)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal.
ICVS/3B's - PT Government Associate Laboratory, Guimarães/Braga, Portugal.

Vishukumar Aimanianda (V)

Unité des Aspergillus, Institut Pasteur, 75015, Paris, France.

Rob Ter Horst (R)

Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Centre, 6500HB, Nijmegen, Netherlands.

Luis Leite (L)

STMO, Instituto Português de Oncologia, 4200-072, Porto, Portugal.

Toine Mercier (T)

Department of Hematology, UZ Leuven, 3000, Leuven, Belgium.
Department of Microbiology and Immunology, KU Leuven, 3000, Leuven, Belgium.

Paulo Pereira (P)

Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, 1649-028, Lisboa, Portugal.

Miguel Fernández-García (M)

Center for Metabolomics and Bioanalysis, Faculty of Pharmacy, San Pablo CEU University, 28668, Madrid, Spain.

Daniela Antunes (D)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal.
ICVS/3B's - PT Government Associate Laboratory, Guimarães/Braga, Portugal.

Cláudia S Rodrigues (CS)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal.
ICVS/3B's - PT Government Associate Laboratory, Guimarães/Braga, Portugal.

Catarina Barbosa-Matos (C)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal.
ICVS/3B's - PT Government Associate Laboratory, Guimarães/Braga, Portugal.

Joana Gaifem (J)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal.
ICVS/3B's - PT Government Associate Laboratory, Guimarães/Braga, Portugal.

Inês Mesquita (I)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal.
ICVS/3B's - PT Government Associate Laboratory, Guimarães/Braga, Portugal.

António Marques (A)

Serviço de Imuno-Hemoterapia, Hospital de Braga, 4710-243, Braga, Portugal.

Nuno S Osório (NS)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal.
ICVS/3B's - PT Government Associate Laboratory, Guimarães/Braga, Portugal.

Egídio Torrado (E)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal.
ICVS/3B's - PT Government Associate Laboratory, Guimarães/Braga, Portugal.

Fernando Rodrigues (F)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal.
ICVS/3B's - PT Government Associate Laboratory, Guimarães/Braga, Portugal.

Sandra Costa (S)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal.
ICVS/3B's - PT Government Associate Laboratory, Guimarães/Braga, Portugal.

Leo Ab Joosten (LA)

Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Centre, 6500HB, Nijmegen, Netherlands.

Katrien Lagrou (K)

Department of Microbiology and Immunology, KU Leuven, 3000, Leuven, Belgium.
Department of Laboratory Medicine, UZ Leuven, 3000, Leuven, Belgium.

Johan Maertens (J)

Department of Hematology, UZ Leuven, 3000, Leuven, Belgium.
Department of Microbiology and Immunology, KU Leuven, 3000, Leuven, Belgium.

João F Lacerda (JF)

Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, 1649-028, Lisboa, Portugal.

António Campos (A)

STMO, Instituto Português de Oncologia, 4200-072, Porto, Portugal.

Gordon D Brown (GD)

MRC Centre for Medical Mycology, University of Aberdeen, Aberdeen, AB25 2ZD, UK.

Axel A Brakhage (AA)

Department of Molecular and Applied Microbiology, Leibniz-Institute for Natural Product Research and Infection Biology, 07745, Jena, Germany.
Institute of Microbiology, Friedrich Schiller University, 07743, Jena, Germany.

Coral Barbas (C)

Center for Metabolomics and Bioanalysis, Faculty of Pharmacy, San Pablo CEU University, 28668, Madrid, Spain.

Ricardo Silvestre (R)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal.
ICVS/3B's - PT Government Associate Laboratory, Guimarães/Braga, Portugal.

Frank L van de Veerdonk (FL)

Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Centre, 6500HB, Nijmegen, Netherlands.

Georgios Chamilos (G)

School of Medicine, University of Crete, 70013, Heraklion, Greece.
Institute of Molecular Biology and Biotechnology, FORTH, 70013, Heraklion, Greece.

Mihai G Netea (MG)

Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Centre, 6500HB, Nijmegen, Netherlands.
Department of Genomics & Immunoregulation, Life and Medical Sciences Institute, University of Bonn, 53115, Bonn, Germany.

Jean-Paul Latgé (JP)

Unité des Aspergillus, Institut Pasteur, 75015, Paris, France.

Cristina Cunha (C)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal.
ICVS/3B's - PT Government Associate Laboratory, Guimarães/Braga, Portugal.

Agostinho Carvalho (A)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057, Braga, Portugal. agostinhocarvalho@med.uminho.pt.
ICVS/3B's - PT Government Associate Laboratory, Guimarães/Braga, Portugal. agostinhocarvalho@med.uminho.pt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH